Skip to main content
. 2021 Oct 12;95(5):336–344. doi: 10.1016/j.anpede.2020.10.007

Table 1.

Epidemiological characteristics and clinical presentation of the patients.

Total Confirmed COVID-19 Unconfirmed COVID-19 P
Patients, n (%) 72 (100%) 40 (55.5%) 32 (44.5%)
Sex, n (%) .622
 Male 46 (63.9%) 27 (67.5%) 19 (59.4%)
 Female 26 (36.1%) 13 (32.5%) 13 (40.6%)
Age (months); median (IQR) 83.5 (16.3−157.5) 76.5 (3.5−161.5) 94 (33−129.8) .642
Comorbidity, n (%)
 Any 14 (19.4) 6 (15) 8 (25) .373
 Heart disease 4 (5.6) 3 (7.5) 1 (3.1)
 Lung disease or asthma 4 (5.6) 1 (2.5) 1 (3.1)
 Renal disease 2 (2.8) 1 (2.5) 3 (9.4)
 Other 4 (5.6) 1 (2.5) 3 (9.4)
Admission, n (%)
 Inpatient ward 32 (44.4) 24 (60) 8 (25) .004
 PICU 3 (4.2) 3 (7.5) 0 .249
Presentation, n (%)
 Respiratory 48 (66.7) 26 (65) 22 (68.8) a
 Malaise 8 (11.1) 2 (5) 6 (18.8)
 Fever without source 7 (9.7) 4 (10) 3 (9.4)
 MIS-C 2 (2.8) 2 (5) 0
 Asymptomatic 1 (1.4) 1 (2.5) 0
 Other 6 (8.3) 5 (12.5) 1 (3.1)
Symptoms, n (%)
 Fever/low-grade fever 59 (81.9) 32 (80) 27 (84.4) .762
 Cough 57 (79.2) 30 (75) 27 (84.4) .392
 Headacheb 28 (56) 16 (64) 12 (46.2) .154
 Diarrhoea 36 (50) 20 (50) 16 (50) 1.000
 Nasal discharge 29 (40.3) 17 (42.5) 12 (37.5) .810
 Respiratory distress 23 (31.9) 12 (30) 11 (34.4) .801
 Cutaneous manifestations 19 (26.4) 10 (25) 9 (28.1) .794
 Myalgiab 15 (29.4) 9 (36) 6 (23) .353
 Vomiting 15 (20.8) 10 (25) 5 (15.6) .392
 Asthenia 15 (20.8) 7 (17.5) 8 (25) .562
 Abdominal pain 13 (18.3) 7 (17.9) 6 (18.8) 1.000
 Sore throatb 12 (22.6) 8 (33.3) 4 (16) .196
 Anosmia/dysgeusia 11 (22.4) 5 (20.8) 6 (24) 1.000
 Neurologic (other) 4 (5.6) 2 (5) 2 (6.3) 1.000
a

Fisher exact test not applicable, variable with more than 2 categories.

b

The headache, myalgia and anosmia/dysgeusia variables were treated as missing values in children under 3 years. The sore throat variable was treated as missing values in children under 2 years.